The Battle for Market Share: Why Biosimilars Struggle to Capture the Market
Humira biosimilars began entering the market in January 2023, with 10 now FDA-approved.
Discover Michael's blog, where he shares his insights and expert analyses on the dynamic world of pharmaceuticals and healthcare. Stay updated with industry trends, and gain perspectives from an accomplished global pharmaceutical executive.